Industry-leading accuracy so you can feel confident in your clear, actionable results, and support along the way.
Missing: mdgn | Show results with:mdgn
INVESTORS · Driven by patient need, we have the potential to transform the treatment of NASH · A Company Focused on Improving Care for Patients with NASH.
Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 ...
7 days ago · Investor Contact Information · Company. Mirion Technologies, Inc. 1218 Menlo Drive Atlanta, GA 30318. T: 770.432.2744 ir@mirion.com · Investor ...
Missing: mdgn | Show results with:mdgn
Our integrated cloud solution is proven to automate pricing, incentive and contract decisions to scale business profitably and grow revenue. Model N is trusted ...
Missing: mdgn | Show results with:mdgn
Stock Snapshot ; Market/Symbol. Nasdaq: AIRG ; Price. 5.60 ; Change. 0.20 (3.70%) ; Volume. 10.10k ; Day Range. 5.355 - 5.60 ...
Missing: mdgn | Show results with:mdgn
The Investor Relations website contains information about Align Technology's business for stockholders, potential investors, and financial analysts.
Missing: mdgn | Show results with:mdgn
Our customers' projects are an investment in the future. Through our partnerships with them, we help make people's lives better. Materion is positioned in high ...
Missing: mdgn | Show results with:mdgn
The Investor Relations website contains information about Amgen Inc.'s business for stockholders, potential investors, and financial analysts.
Missing: mdgn | Show results with:mdgn
The Investor Relations website contains information about Mylan N.V.'s business for stockholders, potential investors, and financial analysts.
Missing: mdgn | Show results with:mdgn